
Opinion|Videos|April 30, 2024
Optimizing Care for Newly Diagnosed Hepatic Encephalopathy
Medical experts discuss the challenges of starting treatment for newly diagnosed, cognitively impaired patients, addressing prescription processes, patient education, and the role of cost, care quality, and convenience in promoting successful medication adherence.
Advertisement
Episodes in this series

Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
COVID-19 Boosters May Offer Head Start Against Future Animal Coronaviruses, But Immune "Imprinting" Complicates the Picture
2
Heal or Harm: Body Protective Compound-157 in the Gray Zone
3
FDA Approves Roflumilast Cream 0.3% for Plaque Psoriasis in Children as Young as 2
4
Cardiovascular Inflammation Persists in Some Patients With CVD Despite Standard Treatment
5










































































































